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Abstract
Following a request from the European Commission, the EFSA Panel on Additives and Products or
Substances used in Animal Feed was asked to deliver a scientific opinion on the safety and efficacy of
Levucell® SC when used in feed for calves and minor ruminant species and camelids at the same
developmental stage. The additive consists of viable cells of Saccharomyces cerevisiae. This species is
considered by EFSA to be suitable for the Qualified Presumption of Safety (QPS) approach to safety
assessment. This approach requires the identity of the strain to be conclusively established. The strain
was found to meet the criteria for the QPS approach in the context of previous opinions and since
concerns are not expected from other components of the additive, Levucell® SC is presumed safe for all
target species, consumers of products derived from animals fed the additive and for the environment.
The Panel considers these conclusions to apply also in the current assessment. In a previous opinion, the
Panel also concluded that the additive is considered an eye irritant but not a dermal irritant or sensitiser
and that inhalation exposure is unlikely. Since the use of the additive in calves and minor ruminant
species and camelids at the same developmental stage is considered unlikely to introduce hazards for
users of the product not already considered as part of the first assessment, these conclusions are still
considered valid. Levucell SC® has the potential to be efficacious in calves at the minimum inclusion level
of 1 9 109 CFU/kg complete feed. The conclusion on efficacy for calves can be extrapolated to minor
ruminant species and camelids at the same developmental stage.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7.
The European Commission received a request from Lallemand SAS2 for renewal of the authorisation
of the product Levucell® SC (Saccharomyces cerevisiae CNCM I-1077), when used as a feed for calves
and minor (pseudo)ruminants species (category: zootechnical additive; functional group: gut flora
stabiliser and digestibility enhancers). In the course of the assessment the applicant clarified that the
target species are calves and minor species and camelids at the same developmental stage.3
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 4(1)
(authorisation of a feed additive or new use of a feed additive). The particulars and documents in
support of the application were considered valid by EFSA as of 25 September 2018.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efficacy of the
product Levucell® SC (Saccharomyces cerevisiae CNCM I-1077), when used under the proposed
conditions of use (see Section 3.1).
1.2. Additional information
The additive Levucell® SC is a preparation of S. cerevisiae CNCM I-1077. EFSA issued several
opinions on the safety and efficacy of this product for the following species: dairy goats and dairy
ewes (EFSA, 2006a; EFSA FEEDAP Panel, 2018), leisure horses (EFSA, 2006b, 2009), lambs for
fattening (EFSA, 2008), dairy cows, cattle for fattening, minor ruminant species and camelids (EFSA
FEEDAP Panel, 2017) and lambs and horses (EFSA FEEDAP Panel, 2019).
The product is currently authorised for use in horses,4 lambs,5 dairy goats and dairy sheep,6 dairy
cows and cattle for fattening.7
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier8 in support of the authorisation request for the use of Levucell® SC as a feed additive.
The European Union Reference Laboratory (EURL) considered that the conclusions and
recommendations reached in the previous assessment regarding the methods used for the control of
the active agent in animal feed are valid and applicable for the current application.9
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Lallemand SAS. 137, 19 Rue des Briquetiers, BP 31702. 59700 Blagnac, France.
3 Technical dossier/Supplementary information April 19.
4 Commission Regulation (EC) No 910/2009 of 29 September 2009 concerning the authorisation of a new use of the preparation
of Saccharomyces cerevisiae CNCM I-1077 as a feed additive for horses (holder of authorisation Lallemand SAS). OJ L 257,
30.9.2009, p. 7.
5 Commission Regulation (EC) No 1293/2008 of 18 December 2008 concerning the authorisation of a new use of
Saccharomyces cerevisiae CNCM I-1077 (Levucell SC20 and Levucell SC10 ME) as a feed additive. OJ L 340, 19.12.2008, p. 38 plus.
6 Commission Regulation (EC) No 226/2007 of 1 March 2007 concerning the authorisation of Saccharomyces cerevisiae CNCM I
1077 (Levucell SC20 and Levucell SC10 ME) as a feed additive. OJ L 64, 2.3.2007, p. 26 plus amendments.
7 Commission Regulation (EC) No 1200/2005 of 26 July 2005 concerning the permanent authorisation of certain additives in
feedingstuffs and the provisional authorisation of a new use of an additive already authorised in feedingstuffs. OJ L 195,
27.7.2005, p. 6 plus amendments.
8 FEED dossier reference: FAD-2018-0049.
9 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/jrcsh/files/finrep-fad-2010-0120-levucell.pdf
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2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efficacy of Levucell® SC
is in line with the principles laid down in Regulation (EC) No 429/200810 and the relevant guidance
documents: Guidance on the assessment of the efficacy of feed additives (EFSA FEEDAP Panel, 2018).
3. Assessment
Levucell® SC11 is a preparation consisting of viable cells of S. cerevisiae (CNCM I-1077) intended
for use as a zootechnical additive (gut flora stabiliser and digestibility enhancer) in feed for calves and
minor ruminant species and camelids at the same developmental stage (i.e. calves of the species Bos
taurus (reared for reproduction, veal production or beef production) from birth until weaning/full
development of the rumen, buffalo calves, goat kids, lambs, calves/kids of species in the family
Cervidae and other species of ruminants, from birth until weaning/full development of the rumen and
calves of Camelus spp. from birth until weaning/full development of the rumen).3
3.1. Characterisation
The product is marketed in two forms, a granulated free-flowing powder, Levucell® SC20, with a
minimum concentration of viable yeast cells of 2 9 1010 colony forming units (CFU)/g of additive and
Levucell® SC10 ME/Titan, with a minimum concentration of viable
yeast cells of 1 9 1010 colony forming units (CFU)/g of additive. The active agent and additive were
fully characterised in a previous opinion; therefore, all data pertaining to composition, purity, physico-
chemical properties and stability described thereof are considered valid also for this application (EFSA
FEEDAP Panel, 2017).
The additive is intended for use in complete feed for calves and minor ruminant species and
camelids at the same developmental stage at the minimum inclusion level of 1 9 109 CFU/kg complete
feed.3
3.2. Safety
The species S. cerevisiae is considered by EFSA to be suitable for the Qualified Presumption of
Safety (QPS) approach to safety assessment (EFSA, 2007, EFSA BIOHAZ Panel, 2017). This approach
requires the identity of the strain to be conclusively established. In a previous opinion (EFSA FEEDAP
Panel, 2017), the identity of the Levucell® active agent was confirmed to be a S. cerevisiae strain.
Accordingly, this strain is considered by EFSA to be suitable for the QPS approach to safety and is
presumed safe for the target species, consumers of products from animals fed the additive and the
environment. Since no concerns are expected from other components of the additive, Levucell® SC
was also considered safe for the target species, consumers of products from animals fed the additive
and the environment. The Panel considers these conclusions to apply also in the current assessment.
In the same opinion, Levucell® SC was considered not a skin irritant or sensitiser but, an eye
irritant. Inhalation exposure was found to be unlikely. The use of the additive with the additional target
species is considered unlikely to introduce hazards for users of the product not already considered as
part of the first assessment. Therefore, the conclusions reached in the previous assessment apply to
the current application.
3.3. Efficacy
3.3.1. Efficacy for calves
The dossier contains three studies, two of which carried out in the same location but in different
periods. In the three studies Levucell® SC20 was used. The two forms are considered equivalent when
used to deliver the same dose.
10 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC) No
1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications and
the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
11 Levucell® SC Titan may be marketed with other tradenames: Levupro® SC20/SC10 ME Titan, Proficell® SC20/SC10 ME Titan,
Lallemand® SC20/SC10 ME Titan.
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No mortality occurred in any of the studies. Inclusion of Levucell SC® in feed led to a significantly greater weight gain and improved feed to gain ratio in
the three studies. This was reached at an inclusion level of approximately 1 9 109 CFU/kg complete feed.
3.3.1.1. Conclusions on efficacy for calves
Levucell SC® has the potential to be efficacious in calves at the minimum inclusion level of 1 9 109 CFU/kg complete feed.
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3.3.2. Efficacy for minor ruminant species and camelids
The efficacy of Levucell SC® for calves has been established at 1 9 109 CFU/kg complete feed.
Considering the physiological similarity of the developmental stage and since the dose proposed for use
with minor species is the same as that demonstrated to be effective in a physiologically similar major
species, and it can be reasonably assumed that the mode of action is the same, the conclusion on efficacy
for calves can be extrapolated to minor ruminant species and camelids at the same developmental stage.
3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for specific requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation15 and Good
Manufacturing Practice.
4. Conclusions
Levucell SC® is considered safe for the target animals, consumers of products derived from treated
animals and the environment.
Levucell® SC is considered an eye irritant but not a dermal irritant or sensitiser. Inhalation exposure
is unlikely.
Levucell SC® has the potential to be efficacious in calves at the minimum inclusion level of
1 9 109 CFU/kg complete feed. The conclusion on efficacy for calves can be extrapolated to minor
ruminant species and camelids at the same developmental stage.
Documentation provided to EFSA/Chronology
Date Event
27/07/2018 Dossier received by EFSA. Saccharomyces cerevisiae CNCM I-1077. July 2018. Submitted by
Lallemand SAS
13/08/2018 Reception mandate from the European Commission
25/09/2018 Application validated by EFSA – Start of the scientific assessment
10/04/2019 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation
(EC) No 1831/2003 – Scientific assessment suspended. Issues: characterisation
25/12/2018 Comments received from Member States
26/04/2019 Reception of supplementary information from the applicant - Scientific assessment re-started
14/05/2019 Opinion adopted by the FEEDAP Panel. End of the Scientific assessment
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